Yoshihiro Sumita - Concepedia

Author

Yoshihiro Sumita

Sumitomo Dainippon Pharma (Japan)

Also Known As

Y Sumita, Y. SUMITA, Y. Sumita, YOSHIHIRO SUMITA, Yoshihiro SUMITA, Yoshihiro Sumita

Publications

987

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Sumitomo Dainippon Pharma (United States)Sumitomo Chemical (United States)

About

Yoshihiro Sumita is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, drug resistance, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	483
2	Biochemistry	6	6	270
3	Health Sciences	5	5	147
4	Natural Sciences	3	3	205
5	Engineering	1	1	235

Yoshihiro Sumita

Publications

919

Citations

H-Index

Page 1

	Year	Citations
New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet Takahiro Ochiya, Yasushi Takahama, Shunji Nagahara, Nature Medicine Cell-based Drug DeliveryNew Delivery SystemEngineeringOligonucleotideGenetic Engineering	1999	235
Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I MASATOMO FUKASAWA, Yoshihiro Sumita, E.T. Harabe, Antimicrobial Agents and Chemotherapy Medicinal ChemistryPharmaceutical ScienceBiochemistryNatural SciencesHuman Dhp-i	1992	130
Comparison of two carbapenems, SM-7338 and imipenem. Affinities for penicillin-binding proteins and morphological changes. Yoshihiro Sumita, MASATOMO FUKASAWA, Takao Okuda The Journal of Antibiotics	1990	77
Structural Features Resulting in Convulsive Activity of Carbapenem Compounds: Effect of C-2 Side Chain. Yoshihiro Sumita, HIROSHI NOUDA The Journal of Antibiotics	1995	75
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338 Yoshihiro Sumita, Manabu Inoue, S Mitsuhashi European Journal of Clinical Microbiology & Infectious Diseases Antimicrobial SusceptibilityHealth SciencesAntibioticsVitro Antibacterial ActivityMedicine	1989	63
Potent activity of meropenem against <i>Escherichia coli</i> arising from its simultaneous binding to penicillin-binding proteins 2 and 3 Yoshihiro Sumita, Masatomo Fakasawa Journal of Antimicrobial Chemotherapy Escherichia ColiAntimicrobial ChemotherapyBacterial PathogensDrug ResistanceSimultaneous Binding	1995	49
Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis Koji Takemoto, Yutaka Yamamoto, Yutaka Ueda, Journal of Antimicrobial Chemotherapy	2006	44
Meropenem Resistance in <i>Pseudomonas aeruginosa</i> Yoshihiro Sumita, MASATOMO FUKASAWA Chemotherapy	1996	37
Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus Yoshihiro Sumita, HIROSHI NOUDA, Katsunori Kanazawa, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyMethicillin-resistant S. AureusDrug ResistanceAntimicrobial ResistanceHealth Sciences	1995	36
Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2-ylthio)carbapenems HISATOSHI SHINAGAWA, HIROSHI YAMAGA, Hitoshi Houchigai, Bioorganic & Medicinal Chemistry BiochemistryAnti-mrsa β-LactamsBiological PropertiesNew SeriesAntibacterial Agent	1997	29

Page 1